GONG Weilei
School of Pharmaceutical Sciences & Institute of Materia Medica, Shandong First Medical University & Shandong Academy of Medical Sciences, Jinan, Shandong 250117, ChinaWANG Lei
School of Pharmaceutical Sciences & Institute of Materia Medica, Shandong First Medical University & Shandong Academy of Medical Sciences, Jinan, Shandong 250117, ChinaYU Yang
School of Laboratory Animal & Shandong Laboratory Animal Center, Shandong First Medical University & Shandong Academy of Medical Sciences, Jinan, Shandong 250117, ChinaLIU Peiqing
School of Pharmaceutical Sciences & Institute of Materia Medica, Shandong First Medical University & Shandong Academy of Medical Sciences, Jinan, Shandong 250117, China;School of Pharmaceutical Sciences, Sun Yat-Sen University, Guangzhou, Guangdong 510006, China1.School of Pharmaceutical Sciences & Institute of Materia Medica, Shandong First Medical University & Shandong Academy of Medical Sciences, Ji'nan, Shandong 250117, China;2.School of Laboratory Animal & Shandong Laboratory Animal Center, Shandong First Medical University & Shandong Academy of Medical Sciences, Ji'nan, Shandong 250117, China;3.School of Pharmaceutical Sciences, Sun Yat-Sen University, Guangzhou, Guangdong 510006, China)
R5
GONG Weilei, WANG Lei, YU Yang, LIU Peiqing. Progress of bilirubin in the mechanism of atherosclerosis[J]. Editorial Office of Chinese Journal of Arteriosclerosis,2024,32(8):712-718.
Copy